We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$2.05B
AUM Growth
-$719M
(-26%)
Cap. Flow
-$710M
Cap. Flow
% of AUM
-34.69%
Top 10 Holdings %
Top 10 Hldgs %
51.88%
Holding
36
New
2
Increased
3
Reduced
27
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Comcast
CMCSA
|
+$49M |
| 3 |
CELG
Celgene Corp
CELG
|
+$37.9M |
| 4 |
Gilead Sciences
GILD
|
+$27.5M |
| 5 |
Biogen
BIIB
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
WFM
Whole Foods Market Inc
WFM
|
+$127M |
| 3 |
Tapestry
TPR
|
+$70.2M |
| 4 |
Amgen
AMGN
|
+$65.3M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$53.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.16% |
| 2 | Technology | 25.79% |
| 3 | Consumer Discretionary | 22.59% |
| 4 | Consumer Staples | 14.73% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Oracle
ORCL
$364B
| $110M | 5.36% |
2,681,833
-1,189,672
| -31% | -$45.3M |
|
2
CVS Health
CVS
$137B
| $108M | 5.29% |
1,446,416
-605,312
| -30% | -$42.8M |
|
|
EMC
3
DELISTED
EMC CORPORATION
EMC
| $108M | 5.27% |
3,938,204
-1,550,337
| -28% | -$40.3M |
|
4
Johnson & Johnson
JNJ
$609B
| $108M | 5.26% |
1,096,640
-330,417
| -23% | -$30.6M |
|
5
Walt Disney
DIS
$170B
| $107M | 5.21% |
1,332,125
-564,654
| -30% | -$43.8M |
|
|
JWN
6
DELISTED
Nordstrom
JWN
| $106M | 5.2% |
1,703,577
-462,052
| -21% | -$27.8M |
|
7
Qualcomm
QCOM
$181B
| $105M | 5.12% |
1,328,744
-545,955
| -29% | -$41.1M |
|
8
Adobe
ADBE
$94.3B
| $104M | 5.08% |
1,582,701
-798,894
| -34% | -$51.2M |
|
9
Mondelez International
MDLZ
$78.3B
| $104M | 5.07% |
3,006,610
-903,578
| -23% | -$30.9M |
|
10
TJX Companies
TJX
$171B
| $103M | 5.03% |
3,393,564
-923,742
| -21% | -$28M |
|
|
11
Apple
AAPL
$4.9T
| $102M | 4.96% |
+5,300,932
| New | +$101M |
|
12
Nike
NKE
$64.9B
| $101M | 4.93% |
2,735,252
-703,682
| -20% | -$26.6M |
|
13
eBay
EBAY
$49.8B
| $100M | 4.9% |
4,315,985
-1,693,565
| -28% | -$39.3M |
|
|
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
| $99.8M | 4.88% |
1,329,519
-709,969
| -35% | -$53.2M |
|
15
Estee Lauder
EL
$29.7B
| $99.1M | 4.84% |
1,481,766
-346,400
| -19% | -$24.1M |
|
16
Costco
COST
$417B
| $98.6M | 4.82% |
883,061
-227,161
| -20% | -$26M |
|
|
17
Biogen
BIIB
$30.4B
| $98.1M | 4.79% |
320,702
+65,026
| +25% | +$20.6M |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $92.4M | 4.51% |
1,324,184
+477,962
| +56% | +$37.9M |
|
|
19
Gilead Sciences
GILD
$167B
| $90.7M | 4.43% |
1,279,301
+350,401
| +38% | +$27.5M |
|
|
20
Tapestry
TPR
$28.6B
| $51.8M | 2.53% |
1,042,540
-1,410,035
| -57% | -$70.2M |
|
|
21
Comcast
CMCSA
$85B
| $47.1M | 2.3% |
+1,883,066
| New | +$49M |
|
22
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $1.64M | 0.08% |
32,581
-1,524
| -4% | -$75.4K |
|
23
Vanguard Extended Market ETF
VXF
$30.5B
| $537K | 0.03% |
6,325
-589
| -9% | -$49.2K |
|
24
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $505K | 0.02% |
27,766
-7,094
| -20% | -$127K |
|
25
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $424K | 0.02% |
7,247
-111
| -2% | -$6.4K |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, WestEnd Advisors held 36 positions worth $2.05B, down 26% from $2.77B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
WestEnd Advisors withdrew a net $710M in Q1 2014, closing 4 positions and reducing 27 holdings. Its most notable exit was Crown Castle, an estimated $130M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, WestEnd Advisors opened a new position in Apple worth $102M.
- WestEnd Advisors's largest Q1 2014 buy was Apple: 5,300,932 shares worth $102M.
- WestEnd Advisors added most to Celgene Corp in Q1 2014, an estimated $37.9M increase.
- WestEnd Advisors's biggest Q1 2014 reduction was Tapestry, cutting an estimated $70.2M.
- WestEnd Advisors fully exited Crown Castle in Q1 2014, selling an estimated $130M.
- WestEnd Advisors's ten largest holdings make up 52% of its $2.05B portfolio in Q1 2014.
- WestEnd Advisors opened 2 new positions and closed 4 in Q1 2014.
- WestEnd Advisors's portfolio value fell 26% quarter-over-quarter to $2.05B.
Based on WestEnd Advisors's 13F filing for Q1 2014, filed 6 May 2014.